News Shared on Time is News Heard !

 
US Republican leader Kevin McCarthy was a simple up-or-down vote from realizing his dream of becoming one of the country’s top statesmen on Tuesday — in a cliffhanger worthy of TV drama “House of Cards” that could as easily end with his career in tatters.
The California congressman is vying for the speakership of the House of Representatives and needs a simple majority — 218 votes if every lawmaker shows up — as the lower chamber of Congress opens for the new term.
Having failed in a previous bid, McCarthy has long coveted the role of Washington’s top legislator, the parliamentary and political leader who presides over House business and is second in line to the presidency.
Yet in the best traditions of the political thriller, there will be intrigue until the credits roll, with the threadbare 222 Republican majority opening the path for a potential rearguard action from anti-McCarthy spoilers.
Six House Republicans — enough to keep McCarthy from securing the gavel — have come out against him, with three saying they are a firm “no” and the rest “almost certainly” opposed.
McCarthy withdrew from the speaker race in 2015 amid a number of blunders and a right-wing revolt.
In a sign of his continuing propensity to divide rather than unify, far right flamethrower Marjorie Taylor Greene and her normally close ally Matt Gaetz had dueling columns in the conservative Daily Caller before Christmas.
“Every single Republican in Congress knows that Kevin does not actually believe anything. He has no ideology,” Gaetz wrote.
Greene, who is believed to have been offered considerable influence in return for her backing, retorted that McCarthy’s opponents were lying “when they claim a consensus House Speaker candidate will emerge.”
– Cloak and dagger –
If the 57-year-old former storekeeper falls short, the process continues to a second ballot, probably also on Tuesday, and McCarthy’s critics get the chance to put forward different candidates.
No credible alternative has been floated publicly, although the most obvious would be House Whip Steve Scalise, a loyal McCarthy deputy who has nevertheless been clear that he has ambitions of his own.
One roadblock to McCarthy’s anointment has been the perception among detractors on his party’s far right that he is insufficiently loyal to Republican former president and 2024 election candidate Donald Trump.
The California Republican has tried to ingratiate himself with the “Never Kevin” crowd, bowing to calls for intensive investigations of Democrats.
McCarthy, who defied a subpoena from the House panel probing the 2021 assault on the Capitol, has promised investigations of President Joe Biden’s family and administration, as well as of the FBI and CIA.
But the more he is seen as giving away the store to critics on the right, the more likely he is to alienate moderates, sparking open war between Senate and House Republicans, where there is already little love lost.
Several of the lawmakers withholding support from McCarthy said the House should block bills from Republican senators who voted for the $1.7 trillion government funding bill that passed before Christmas.
In a sign of the leverage they hold over him, McCarthy agreed, pledging that those bills would be “dead on arrival in the House” if he is speaker.
But he was largely ignored by the Senate leadership and much of the rank and file, as the bill passed by 68 votes to 29 — leaving his threat looking unsustainable.
Strategists expect fraught cloak-and-dagger talks between the two sides in the event of a McCarthy defeat that could see the emergence of a consensus Republican who can lock in 218 votes with some Democratic support.
There has been behind-the-scenes speculation about how long McCarthy might stay in Congress if he were to lose out again.
Allies point out that he would not be short of private-sector job offers.
But some Congress watchers believe the career politician has the place in his blood and would want to remain as a backbencher.
AFP

By john

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.